- Home
- BFRG vs BOLT Comparison
BFRG vs BOLT Comparison
Compare BFRG & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFRG
- BOLT
- Stock Information
- Founded
- BFRG 2017
- BOLT 2015
- Country
- BFRG United States
- BOLT United States
- Employees
- BFRG N/A
- BOLT N/A
- Industry
- BFRG Retail: Computer Software & Peripheral Equipment
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- BFRG Technology
- BOLT Health Care
- Exchange
- BFRG Nasdaq
- BOLT Nasdaq
- Market Cap
- BFRG 16.4M
- BOLT 16.8M
- IPO Year
- BFRG 2023
- BOLT 2021
- Fundamental
- Price
- BFRG $1.69
- BOLT $0.32
- Analyst Decision
- BFRG
- BOLT Buy
- Analyst Count
- BFRG 0
- BOLT 3
- Target Price
- BFRG N/A
- BOLT $2.50
- AVG Volume (30 Days)
- BFRG 110.1K
- BOLT 812.4K
- Earning Date
- BFRG 05-13-2025
- BOLT 05-12-2025
- Dividend Yield
- BFRG N/A
- BOLT N/A
- EPS Growth
- BFRG N/A
- BOLT N/A
- EPS
- BFRG N/A
- BOLT N/A
- Revenue
- BFRG N/A
- BOLT $3,638,000.00
- Revenue This Year
- BFRG N/A
- BOLT N/A
- Revenue Next Year
- BFRG N/A
- BOLT $97.29
- P/E Ratio
- BFRG N/A
- BOLT N/A
- Revenue Growth
- BFRG N/A
- BOLT N/A
- 52 Week Low
- BFRG $1.23
- BOLT $0.27
- 52 Week High
- BFRG $4.84
- BOLT $0.78
- Technical
- Relative Strength Index (RSI)
- BFRG 44.91
- BOLT 48.17
- Support Level
- BFRG $1.64
- BOLT $0.29
- Resistance Level
- BFRG $1.90
- BOLT $0.33
- Average True Range (ATR)
- BFRG 0.10
- BOLT 0.04
- MACD
- BFRG -0.01
- BOLT 0.00
- Stochastic Oscillator
- BFRG 17.80
- BOLT 31.19
About BFRG Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.